Lescol
- Product NDC
- 66758-211
- 11-digit product format
- 667580211
- Labeler code
- 66758
- Product ID
- 66758-211_726ea2db-f1b0-4b73-a515-02157db88a42
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- fluvastatin sodium
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Sandoz Inc
- Application
- NDA021192
- Marketing category
- NDA
- Marketing start
- 2000-10-06
- Substance
- FLUVASTATIN SODIUM
- Active strength
- 80 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lescol
- Brand name suffix
- XL
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FLUVASTATIN SODIUM | 80 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | PYF7O1FV7F |
| Rxcui | 360507, 687048 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 66758-211-01 | LescolXL | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | | 1 |
| 66758-211-31 | LescolXL | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 66758-211 | LESCOL XL (FLUVASTATIN SODIUM) TABLET, EXTENDED RELEASE [SANDOZ INC] | 1 | Current NDC, 2 package rows | 20240805_726ea2db-f1b0-4b73-a515-02157db88a42.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 66758-211-01 | 66758021101 | 100 in 1 BOTTLE | | | | Historical |
| 66758-211-31 | 66758021131 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (66758-211-31) | 2024-08-02 | No | No | Current |